je.st
news
Avalanche Biotechnologies: Unsustainable Price Presents Attractive Short Opportunity
2014-12-16 12:35:54| Biotech - Topix.net
When compared to its closest peer, the company appears to be significantly overvalued, and at more reasonable multiples Avalanche could see 50% downside. The stock has outrun its fundamentals, its story, and even optimistic analyst price targets, which positions it well for a short opportunity.
Tags: price
short
opportunity
presents
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||